Pages that link to "Q42689631"

The following pages link to Evaluation of the effect of gain on the meal response of an automated closed-loop insulin delivery system (Q42689631):

Displaying 26 items.

• In silico assessment of biomedical products: The conundrum of rare but not so rare events in two case studies (Q30252581) (← links)
• Use of a food and drug administration-approved type 1 diabetes mellitus simulator to evaluate and optimize a proportional-integral-derivative controller (Q30416614) (← links)
• Closed-Loop Insulin Delivery Utilizing Pole Placement to Compensate for Delays in Subcutaneous Insulin Delivery (Q30424297) (← links)
• Diabetes: Models, Signals, and Control (Q30434551) (← links)
• Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial (Q30434940) (← links)
• Physical activity into the meal glucose-insulin model of type 1 diabetes: in silico studies (Q30437503) (← links)
• Dipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes. (Q34589793) (← links)
• The Effect of Insulin Feedback on Closed Loop Glucose Control (Q34894471) (← links)
• Inhibition of dipeptidylpeptidase IV activity as a therapy of type 2 diabetes (Q36580608) (← links)
• A Run-to-Run Control Strategy to Adjust Basal Insulin Infusion Rates in Type 1 Diabetes (Q36838643) (← links)
• Past, present, and future of insulin pump therapy: better shot at diabetes control (Q36924597) (← links)
• Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies (Q37404440) (← links)
• Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes (Q37404470) (← links)
• Artificial pancreas: an emerging approach to treat Type 1 diabetes (Q37538736) (← links)
• Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus (Q37735838) (← links)
• Physiologic insulin delivery with insulin feedback: A control systems perspective (Q37776811) (← links)
• Pharmacokinetic Applications of Microdevices and Microsampling Techniques (Q37810209) (← links)
• Closed-loop insulin delivery: from bench to clinical practice (Q37846089) (← links)
• How technology has changed diabetes management and what it has failed to achieve (Q37972355) (← links)
• The use of reinforcement learning algorithms to meet the challenges of an artificial pancreas (Q38131064) (← links)
• In Vivo Study of a Polymeric Glucose-Sensitive Insulin Delivery System Using a Rat Model (Q39844333) (← links)
• The artificial pancreas: how sweet engineering will solve bitter problems (Q40256085) (← links)
• A feasibility study of bihormonal closed-loop blood glucose control using dual subcutaneous infusion of insulin and glucagon in ambulatory diabetic swine (Q42599748) (← links)
• Extremum Seeking Control for Personalized Zone Adaptation in Model Predictive Control for Type 1 Diabetes (Q64461481) (← links)
• Closed-Loop Insulin Delivery: We're “Virtually” There (Q82971524) (← links)
• A New Animal Model of Insulin-Glucose Dynamics in the Intraperitoneal Space Enhances Closed-Loop Control Performance (Q92616775) (← links)